ReviewEFORT open reviews2019
Registry stakeholders.
Review in EFORT open reviews, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Online education for rare genetic diseases: a systematic review.Orphanet journal of rare diseases · 2025Pooled it
- Maximising the Quality of Stroke Care: Reporting of Data Collection Methods and Resourcing in National Stroke Registries: A Systematic Review.Journal of medical systems · 2024Pooled it
- Quality and Utility of European Cardiovascular and Orthopaedic Registries for the Regulatory Evaluation of Medical Device Safety and Performance Across the Implant Lifecycle: A Systematic Review.International journal of health policy and management · 2023Pooled it
- Stakeholders' perspectives on HIV prevention in the Czech Republic: a qualitative study.Frontiers in public health · 2026Article
- Adverse local tissue reactions in arthroplasty: opportunities and challenges for a common terminology across scientific, clinical and regulatory fields.EFORT open reviews · 2025Article
- Navigating barriers to real-world evidence utilization for drug regulatory affairs and market access in Saudi Arabia.Frontiers in pharmacology · 2025Article
- Leaving no patient behind! Expert recommendation in the use of innovative technologies for diagnosing rare diseases.Orphanet journal of rare diseases · 2024Review
- Stakeholder Insights into Czech Performance-Based Managed Entry Agreements: Potential for Transformative Change in Pharmaceutical Access?Healthcare (Basel, Switzerland) · 2024Article
- To the Editor: Isfahan Joint Replacement Registry: Study Protocol.Advanced biomedical research · 2023Article
- The role of community engagement toward ensuring healthy lives: a case study of COVID-19 management in two Ghanaian municipalities.Frontiers in public health · 2023Article
- Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1Cephalalgia : an international journal of headache · 2022Article
- Orthopedic Coordinated Registry Network (Ortho-CRN): advanced infrastructure for real-world evidence generation.BMJ surgery, interventions, & health technologies · 2022Review
- The First Report of the International Cartilage Regeneration and Joint Preservation Society's Global Registry.Cartilage · 2021Review
- The rise of registry-based research: a bibliometric analysis.Acta orthopaedica · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clinical registries are health information systems, which have the mission to collect multidimensional real-world data over the long term, and to generate relevant information and actionable knowledge to address current serious healthcare problems.This article provides an overview of clinical registries and their relevant stakeholders, focussing on registry structure and functioning, each stakeholder's specific interests, and on their involvement in the registry's information input and output.Stakeholders of clinical registries include the patients, healthcare providers (professionals and facilities), financiers (government, insurance companies), public health and regulatory agencies, industry, the research community and the media.The article discusses (1) challenges in stakeholder interaction and how to strengthen the central role of the patient, (2) the importance of adding cost reporting to enable informed value choices, and (3) the need for proof of clinical and public health utility of registries.In its best form, a registry is a mission-driven, independent stakeholder-registry team collaboration that enables rapid, transparent and open-access knowledge generation and dissemination. Cite this article:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.